Page 2 - Healthcare Sector

IHH inks Fortis-Gleneagles O&M deal to strengthen pan-India platform

Under the agreement, Fortis will manage operations of six Gleneagles hospitals and one clinic, earning a monthly fee and expanding its bed capacity and national presence

Diagnostic firm Aarthi Scans eyes North India, lines up ₹350 cr investment

Chennai-based Aarthi Scans plans to add 65 new centres by 2030, with 90% in North India, while exploring fitness diagnostics and targeting a Rs 600 crore turnover

Tricog, Omron eye 100 mn patient screenings for cardiac health by 2030

Tricog Health and Omron aim to screen 100 million patients for cardiac health by 2030 with KeeboHealth, an AI-powered connected health platform integrating remote monitoring & real-time data analytics

Porinju Veliyath portfolio stock zooms 20% on huge volumes. Do you own?

Shares of Kerala Ayurveda zoomed 20% to ₹511.70 on the BSE in Monday's intra-day trade with 2.87 million shares representing 23.9% of total equity changing hands till 1:11 PM.

Jhunjhunwala family-backed firm's stock slides 4% after large trades

Inventurus Knowledge Solutions shares fell after a 1.5% stake changed hands in a block deal; buyer and seller unknown

Narayana, Max Healthcare shares gain up to 5%, hit new highs in weak market

India's healthcare sector is on the cusp of significant transformation, driven by increased public and private investments, policy initiatives, and demographic shifts, believe analysts.

OneSource eyes weight-loss drug boost to order book

Global drugmakers, including generic drug manufacturers in India, are racing to develop their versions of blockbuster injectable obesity drugs from Denmark's Novo Nordisk and U.S.-based Eli Lilly

Indegene shares slump 4% after block trades; Here's the likely seller

Indegene shares fell after 12 per cent equity, changed hands in two block trades

Zydus enters biologics CDMO market with $125 million acquisitions

Zydus Lifesciences will acquire two US biologics manufacturing facilities from Agenus for up to $125 million, gaining immediate manufacturing capabilities and expanding its global presence

Apollo Hospitals to gain from hospital growth, digital business breakeven

Apollo anticipates a 140 basis points hit to operating profit margins in FY26 due to new hospitals

Datanomics: Rising Covid cases put spotlight on India's healthcare system

Without urgent boosts in investment, experts warn India will struggle to meet both everyday and emergency health demands

Quadria closes $1.07 bn healthcare fund, seeks growth in India and S Asia

Singapore-based company says it has largest dedicated healthcare PE fund for South and Southeast Asia

Capacity expansion, focus on growth segment drive BirlaNu volume growth: MD

Focus on growth segments and capacity expansion boosted CKA Birla Group company BirlaNu's volumes in the March quarter and FY2024-25, according to Managing Director and CEO Akshat Seth. BirlaNu reported an 80 per cent surge in volumes for the March quarter, with pipes and construction chemicals driving the momentum, Seth said. Full fiscal year saw a 57 per cent increase in revenue and a 76 per cent rise in volumes, he added. The construction chemicals and pipes manufacturer doubled its AAC block capacity in Chennai to 4 lakh cubic meters per year and launched Parador in India, marking its entry into the home and interior space, Seth said. The company also introduced organic-based stabilisers (OBS) in uPVC pipes, eliminating heavy metals and setting new benchmarks for health and sustainability in potable water solutions. "The transition to OBS technology in our uPVC pipes reflects our focus on reducing environmental impact while delivering the highest quality to our customers," said

India's ortho implant sector may hit $5 billion by FY28 on strong demand

India's orthopaedic and cardiac implant sector is expected to reach USD 4.5-5 billion by 2027-28, mainly driven by strong domestic demand and gradually growing exports, a report said on Monday. Currently, the orthopaedic and cardiac implant sector, including exports, stood at USD 2.4-2.7 billion in FY24, according to a report by CareEdge Ratings. The growth in the sector is led by increasing per capita income, greater healthcare awareness, ageing population, expanding healthcare infrastructure, and broadening insurance coverage, it stated. The report said that domestic manufacturers have grown at a faster pace than the dominant foreign MNCs in recent years, aided by their price competitiveness and a gradual build-up of an efficacy and safety track record. The segment is dominated by the presence of foreign multinational companies, which largely import the implants and sell them in India as the implant business requires strong technological capabilities, a proven track record of saf

Pristyn Care opens 3 hospitals in NCR, targets 50 by FY28 public listing

Healthtech firm Pristyn Care moves from asset-light model to hospital ownership, aiming for 50 hospitals, Rs 2,000 crore revenue and 20% Ebitda by FY28 IPO

HexaHealth closes Series A round of $12 mn to redefine India surgical care

Other participants included Enzia Ventures and ITI Growth Opportunities Fund, along with existing investors Chiratae Ventures and Omidyar Network India

Max Healthcare Institute to invest Rs 6,000 cr to add 3,700 beds by 2028

Max Healthcare Institute Ltd will invest Rs 6,000 crore by 2028 to add 3,700 beds across key locations in India, its Chairman and Managing Director Abhay Soi said on Tuesday. Max Healthcare, which operates 22 healthcare facilities with around 5,000 beds currently could have around 30 hospitals by 2028, Soi told PTI. Speaking at the sidelines of the inauguration of Max Super Speciality Hospital, Dwarka, a 300-bed greenfield facility, he said the company will be "reinvesting whatever we generate over the next 10 years to create healthcare assets". "This year alone, we are opening four (hospitals). This (Dwarka) was the first of the four," Soi said. Max Healthcare plans to inaugurate three other hospitals in Mohali, Mumbai, and Saket, New Delhi later this year. The inauguration of the Dwarka hospital is a strategic step in Max Healthcare's broader expansion plan to add 3,700 beds across key locations in India by 2028, the company said. "Some existing hospitals will be expanded and s

These 3 pharma stocks have surged over 50% in April; check full list here

A total of 11 pharma and healthcare-related stocks have rallied more than 20% thus far in April on hopes of a likely softer tariff-related stance by the US President Donald Trump.

5 pharma stocks that you should stay away from given their tech charts

Technical charts hint that pharma shares such as Cipla, Lupin, Sun Pharma, Zydus Lifesciences and Gland Pharma could slide up to 23% as Trump tariff threat on pharma import looms.

Apple's AI-powered health assistant will tell you how to keep fit: Details

Likely to be launched at the annual Worldwide Developers Conference next year, Apple is training the AI-powered health assistant to offer personalised health tracking and insights for users